CanCure LLC focuses on developing novel immunotherapies for cancer patients who lack effective treatment options. Their leading technology, CB-10, is a promising therapeutic antibody with strong preclinical results and is ready for clinical trials to offer potential cures or life extension for patients with metastatic diseases.